Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiologyResearch article Published on 2020-11-012022-10-05 Journal: Transfusion clinique et biologique : journal de la [Category] SARS, 치료법, [키워드] addition Algeria Anticoagulant treatment Anticoagulants Blood cause composed Consensus coronavirus disease COVID-19 death Deceased Diagnostic Criteria DIC discharge Disseminated intravascular coagulation dysfunction Hemostasis hospital hypercoagulability incidence indication intensive care maintain observation outbreak Patient patients with COVID-19 prevention severe COVID-19 shown Spread the epidemic Thromboprophylaxis thrombosis transfusion Treatment Wuhan, China [DOI] 10.1016/j.tracli.2020.09.004 [Article Type] Research article
Blood component use in critical care in patients with COVID-19 infection: a single-centre experienceArticle Published on 2020-11-012023-07-11 Journal: British Journal of Haematology [Category] SARS, [키워드] bleeding COVID-19 Critical care transfusion [DOI] 10.1111/bjh.17007 PMC 바로가기
Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial중증 COVID-19 환자의 회복기 혈장 수혈 요법- 안전성, 효능 및 용량 반응 연구: 2상 무작위 대조 시험 연구 프로토콜의 구조화된 요약Letter Published on 2020-10-262022-08-13 Journal: Trials [Category] MERS, SARS, 임상, [키워드] (neutrophil 24 hour 24 hours allergic allergic reaction Antibody titre Arm ARMS automated blinded Blinding body temperature BSMMU Care checked Clinical improvement collaboration collected comparator computer Controlled Controlled trial convalescent plasma COVID-19 creatinine criteria CRP CT scan deaths defined diastolic discharge dissemination Donor donors dose dose response effective effective dose Efficacy Efficacy and safety element ELISA end point enrolled Evidence evidence of excluded expected FiO2 generate Health Organization hospital Hospital stay ICU identify in-hospital mortality inclusion criteria initial intervention arms Laboratory laboratory parameter Laboratory parameters Laboratory tests lactating women lung lymphocyte multi-arm multicentre neutralizing antibody neutrophil normality number objective open outcome Oxford oxygen oxygen saturations PaO2 paO2/fiO2 participant Participants Patient PCR assay performed plasma Plasma transfusion positive pregnant Primary outcome proportion protocol random number table randomised Randomized controlled trial RCT receive recorded recording recruit recruited recruitment reduction in required respiratory respiratory distress respiratory rate respiratory symptoms room air RT-PCR RT-PCR assay Sample size sample size calculation SARS-CoV-2 secondary outcome serum creatinine Serum ferritin Seven Severe case severe cases severe COVID-19 severe COVID-19 patient severe COVID-19 patients Severe patient severe patients Severe respiratory distress Sex SGOT SGPT SpO2 sputum standard care status Study protocol Support systolic the patient therapy These data titre transfusion Treatment Trial university University of Oxford ventilator website World Health Organization X-ray [DOI] 10.1186/s13063-020-04734-z PMC 바로가기 [Article Type] Letter
Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent IndividualsObservation Published on 2020-10-162022-10-29 Journal: mBio [Category] COVID-19, MERS, SARS, [키워드] absence acute COVID-19 acute respiratory syndrome Analysis approach Clinical efficacy clinical trial collected convalescent convalescent individual convalescent plasma convalescent plasma trial coronavirus coronavirus disease COVID-19 COVID-19 patient cross-reactivity D614G variant Decline Donor effective vaccine Efficacy ELISA evaluate for inclusion globe glycoprotein Humoral response IgA IgG IgM individual Infection interval neutralization neutralization activity neutralize Neutralizing activity neutralizing antibody Neutralizing titer onset of symptom patients performed plasma plasma neutralization activity positive Prevent PROTECT pseudoparticle RBD repeated required resolution of symptoms response Safe SARS-CoV-2 SARS-COV-2 infection significant decrease spike spike glycoproteins Symptoms therapeutic options therapy thought transfer transfusion treat Treatment Vaccine while wild-type SARS-CoV-2 [DOI] 10.1128/mBio.02590-20 PMC 바로가기 [Article Type] Observation
Safety and Efficacy of Convalescent Plasma to Treat Severe COVID-19: Protocol for the Saudi Collaborative Multicenter Phase II StudyProtocol Published on 2020-10-022022-10-29 Journal: JMIR Research Protocols [Category] COVID-19, [키워드] 30-Day mortality antibodies antibody benefit blood donor both group Characteristics China clinically Cohort Comparator group Control control group convalescent plasma Coronaviruses COVID-19 COVID-19 pandemic CP infusion criteria detect Diagnosis disease Donor effective Efficacy expected feasibility Hospital stay Identifier immunology inclusion criteria Infectious disease initial interim analysis Interim report laboratory characteristics lack likelihood management Ministry of Health morbidity and mortality multicenter National objective outcome outcomes passive immunity Patient patients patients with COVID-19 phase propensity score matching protocol randomization Rapid test receive recipient recruited recruitment Registration Regulation report Result Safety SARS-CoV-2 SARS-CoV-2 antibody Saudi Arabia severe COVID-19 therapy total sample size transfusion treated Treatment two group Vaccine [DOI] 10.2196/23543 PMC 바로가기 [Article Type] Protocol
First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemiaShort communication Published on 2020-10-012022-10-05 Journal: Transfusion and apheresis science : official journ [Category] SARS, 치료제, [키워드] adverse event Anemia antiviral drug Asymptomatic children Clinical course convalescent plasma correlation COVID-19 Critical diagnosed Diagnosis eliminated immune observé Pancytopenia Patient positive SARS-CoV-2 SARS-COV-2 infection severe COVID-19 the disease therapy transfusion Treatment [DOI] 10.1016/j.transci.2020.102866 [Article Type] Short communication
Successful treatment of a centenarian with coronavirus disease 2019 (COVID-19) using convalescent plasmaShort communication Published on 2020-10-012022-10-05 Journal: Transfusion and apheresis science : official journ [Category] SARS, 치료법, [키워드] antiviral therapy clinical symptom complete blood count convalescent plasma coronavirus disease Coronavirus disease 2019 cough COVID-19 decreased sharply diagnosed with COVID-19 Dyspnea effective Elderly patient increased risk Inflammatory indicators Laboratory male management Patient Result SARS-CoV-2 viral load the patient transfusion Treatment undetectable Viral load vital signs [DOI] 10.1016/j.transci.2020.102820 [Article Type] Short communication
Trends and targets of various types of stem cell derived transfusable RBC substitution therapy: Obstacles that need to be converted to opportunity다양한 형태의 줄기세포 유래 수혈적혈구 대체요법의 동향 및 목표: 기회로 전환되어야 할 장애물Review Published on 2020-10-012022-09-11 Journal: Transfusion and apheresis science : official journ [Category] 비임상, [키워드] approach artificial artificial intelligence Bioreactors Blood Blood Group blood supply breath Cell cellular clinical trial Combination complex Compliance COVID-19 Critical Culture dependency Donor Efficiency embryonic employment example expansion Expansion media GMP GMP regulatory processes hematological Hematopoietic stem cell hematopoietic stem cells highlight in vitro In-vitro induced Induced pluripotent stem cell life maintenance media metabolic pathway metabolic pathways metabolite metabolites New obstacle outbreak overcome pandemic produced RBC RBCs regenerative regenerative medicine Regulatory required Safe stability STEM stem cell stem cells target Transfusable RBC bioproducts. transfusion trend Variability [DOI] 10.1016/j.transci.2020.102941 PMC 바로가기 [Article Type] Review
Treatment with convalescent plasma for COVID-19 patients in Wuhan, China중국 우한에서 코로나19 환자를 위한 회복기 혈장 치료Case Reports Published on 2020-10-012022-09-12 Journal: Journal of medical virology [Category] Coronavirus, 진단, [키워드] abnormality ABO-compatible convalescent plasma acute respiratory syndrome adverse effect alleviation of symptoms Analysis anti-SARS-CoV-2 antibody changes in consolidation convalescent plasma Convalescent plasma therapy coronavirus coronavirus disease COVID-19 COVID-19 pandemic COVID-19 patient COVID-19 patients effective Efficacy elicited eliminating enrolled evaluate Features ground-glass opacity increase in indicate indicated Intervention Laboratory tests laboratory-confirmed outbreak Patient public health radiologic SARS-CoV-2 serologic therapy throat swab transfusion Treatment virus was determined Wuhan, China [DOI] 10.1002/jmv.25882 PMC 바로가기 [Article Type] Case Reports
Is blood transfusion safe during the COVID-19 pandemic?Editorial Published on 2020-09-172022-10-31 Journal: Future Science OA [Category] COVID-19, [키워드] Blood blood products coronavirus COVID-19 Safe transfusion Transmission [DOI] 10.2144/fsoa-2020-0116 PMC 바로가기 [Article Type] Editorial